We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
US-based PureTech Health has signed a licensing and equity agreement with Swiss company Novartis to advance two clinical-stage programmes targeting the mechanistic target of...